Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.
Journal: Handbook of experimental pharmacology
Published: April 09, 2021
Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients.
Journal: Journal of clinical medicine
Published: January 26, 2021
Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review.
Journal: Anesthesia and analgesia
Published: December 17, 2020
Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo.
Journal: Journal of psychopharmacology (Oxford, England)
Published: August 27, 2020
Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.
Journal: Journal of opioid management
Published: May 07, 2019
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 06, 2018
Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: October 15, 2018
Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.
Journal: Journal of psychopharmacology (Oxford, England)
Published: January 25, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026